Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Novartis Pharmaceuticals Corporation, and Pfizer Inc.

Community Practice Connection™: 4th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards.

Release Date: September 3, 2020
Expiration Date: September 3, 2021

Activity Overview

This Community Practice Connection program provides a review of some key highlights from the virtual meeting of the 4th Annual International Congress on Oncology & Pathology: Towards Harmonization of Pathology and Oncology Standards. This is a multi-media activity featuring text-based content and video interviews of expert faculty that were presented online at the live meeting and focuses on new diagnostic tools, actionable mutations, targeted treatment, and immunotherapy options for non-small cell lung cancer (NSCLC).

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Novartis Pharmaceuticals Corporation, and Pfizer Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, investigators, and other health care professionals interested in the treatment of patients with cancer are also invited to attend.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify recent advancements to understand current and emerging biomarkers among commonly encountered malignancies
  • Analyze pathology-associated disparities and variations in care of patients with cancer
  • Apply current clinical evidence and evolving guidelines in cancer pathology to tailor patient testing and treatment protocols
  • Formulate multidisciplinary strategies to optimize cancer diagnosis and management
  • Outline the roles of genomic and targeted assays in management of patients with cancer

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Balazs Halmos, MD, MS
Balazs Halmos, MD, MS
Professor of Clinical Medicine
Director, Thoracic Medical Oncology
Director, Clinical Cancer Genetics
Albert Einstein College of Medicine/
Montefiore Medical Center
Bronx, NY

Disclosures: Grant Research Support: AbbVie, Advaxis, Amgen, AstraZeneca, Blueprint Medicines, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Guardant Health, Merck, Mirati Therapeutics, Novartis, Pfizer, Takeda; Consultant: Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Guardant Health, Ignyta, Novartis, Pfizer, Spectrum Pharmaceuticals, Turning Point Therapeutics; Speakers Bureau: AbbVie, Amgen, AstraZeneca, Advaxis, Blueprint Medicines, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Guardant Health, Merck, Mirati Therapeutics, Pfizer, Novartis, Takeda; Shareholder: Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Guardant Health, Ignyta, Novartis, Pfizer, Spectrum Pharmaceuticals, Turning Point Therapeutics; Other: AbbVie, Advaxis, Amgen, AstraZeneca, Blueprint Medicines, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Guardant Health, Merck, Mirati Therapeutics, Novartis, Pfizer, Takeda

Lynette M. Sholl, MD
Lynette M. Sholl, MD
Associate Professor, Pathology
Harvard Medical School
Associate Pathologist, Pathology
Brigham and Women’s Hospital
Boston, MA

Disclosures: Grant Research Support: Roche; Consultant: AstraZeneca, EMD Serono, Foghorn, Therapeutics, Loxo Oncology; Other: Travel support- Bristol Myers Squibb

Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
Leslye M. Heisler Associate Professor for Lung Cancer Excellence
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

Disclosures: Grant Research Support: MacroGenics, Merck, AstraZeneca; Consultant: AstraZeneca, Bristol Myers Squibb, Celgene, Genentech, Eli Lilly; Other: AstraZeneca, MacroGenics, Merck

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
27282930
Filter By